Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
Chemotherapy has become the global standard treatment for patients with metastatic or unresectable gastric cancer (GC), although outcomes remain unfavorable. Many molecular-targeted therapies inhibiting signaling pathways of various tyrosine kinase receptors have been developed, and monoclonal antib...
Saved in:
Main Authors: | Mikito Inokuchi, Yoshitaka Fujimori, Sho Otsuki, Yuya Sato, Masatoshi Nakagawa, Kazuyuki Kojima |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/796380 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Postoperative Complications of Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Gastric Cancer in a Meta-Analysis of High-Quality Case-Controlled Studies
by: Mikito Inokuchi, et al.
Published: (2016-01-01) -
Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer
by: Ema Mitsui, et al.
Published: (2025-01-01) -
miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
by: Shuxia Tian, et al.
Published: (2020-01-01) -
BTK inhibitors are a possible emerging therapeutic target for gastric cancer
by: José Darío Portillo-Miño, et al.
Published: (2025-03-01) -
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01)